Neuropharmacological Mechanisms, Clinical Efficacy, and Safety Profiles of Valeriana officinalis and Hypericum perforatum: A Comprehensive Review

Abstract

Neurological and psychiatric disorders, particularly anxiety, depression, and sleep disturbances, represent global health challenges. This comprehensive review evaluates the phytotherapeutic potential, neuropharmacological mechanisms, and clinical outcomes of Valeriana officinalis (Valerian) and Hypericum perforatum (St. John's Wort). Valerian primarily modulates the GABAergic system through valerenic acid, acting as a safe alternative for insomnia and mild anxiety. Conversely, St. John's Wort exhibits significant antidepressant efficacy via hyperforin and hypericin, modulating monoamine neurotransmitters similarly to conventional antidepressants. While both botanicals demonstrate strong clinical efficacy with favorable tolerability profiles compared to synthetic alternatives like benzodiazepines and SSRIs, severe drug-drug interactions, particularly mediated by St. John's Wort via Cytochrome P450 (CYP3A4) induction, necessitate cautious clinical application. This review synthesizes current botanical, phytochemical, and pharmacological data to guide evidence-based clinical use.